Killing cancer cells by targeted drug-carrying phage nanomedicines - Wikidata - awgldk - TriplyDB

Killing cancer cells by targeted drug-carrying phage nanomedicines

Killing cancer cells by targeted drug-carrying phage nanomedicines

http://www.wikidata.org/entity/Q21256651

about

Genetically Engineered Phages: a Review of Advances over the Last Decade Ribosome-inactivating proteins: from plant defense to tumor attack Hybrid nanoparticles for detection and treatment of cancer Chemical strategies for the covalent modification of filamentous phage Refactored M13 bacteriophage as a platform for tumor cell imaging and drug delivery Landscape phage ligands for PC3 prostate carcinoma cells Functional viral metagenomics and the next generation of molecular tools Synthetic phage for tissue regeneration Expanding the versatility of phage display I: efficient display of peptide-tags on protein VII of the filamentous phage.Recombinant lambda-phage nanobioparticles for tumor therapy in mice models.Viral nanoparticles as platforms for next-generation therapeutics and imaging devices Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro.PHAST: a fast phage search tool.Novel p16 binding peptide development for p16-overexpressing cancer cell detection using phage display.Targeting glioblastoma via intranasal administration of Ff bacteriophages.Isothermal rolling circle amplification of virus genomes for rapid antigen detection and typing.Enhancing and initiating phage-based therapies.Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer.Fluorescence lifetime endoscopy using TCSPC for the measurement of FRET in live cells.Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies.Improved binding activity of antibodies against major histocompatibility complex class I chain-related gene A by phage display technology for cancer-targeted therapy.NANOSCALE SELF-ASSEMBLY FOR DELIVERY OF THERAPEUTICS AND IMAGING AGENTS.Design of virus-based nanomaterials for medicine, biotechnology, and energy.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.Phage-Enabled Nanomedicine: From Probes to Therapeutics in Precision Medicine Virus engineering: functionalization and stabilization.Functionalization of protein-based nanocages for drug delivery applications.Chemically Modifying Viruses for Diverse Applications.Ff-nano, short functionalized nanorods derived from Ff (f1, fd, or M13) filamentous bacteriophage.The return of the phage.A Bacteriophage Mediated Gold Nanoparticles Synthesis and Their Anti-biofilm Activity.Translocation Pathway-Dependent Assembly of Streptavidin- and Antibody-Binding Filamentous Virus-Like Particles.Targeting of phage particles towards endothelial cells by antibodies selected through a multi-parameter selection strategy.Engineering building blocks for self-assembling protein nanoparticles Probing the viral metallome: searching for metalloproteins in bacteriophage λ-- the hunt begins.A plant derived multifunctional tool for nanobiotechnology based on Tomato bushy stunt virus.Bacteriophages as templates for manufacturing supramolecular structures.Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.Real-time femtomolar detection of cancer biomarkers from photoconjugated antibody-phage constructs.

P2860

Q26744156-6FF4A25B-5B55-43D7-81DA-E44047F522A2 Q26828935-43BF5D17-49BC-4E40-AF74-5E24E7622736 Q26849404-DEE28D40-727B-454F-B9A7-431F8FB68C85 Q26992196-3773A2D1-3F7B-4BA5-9C43-61C4D404E04C Q30415136-9155A068-F0AC-43A7-A3BE-7A08A0CF0787 Q33534585-8D1372B1-4439-4617-9C52-453E026AC5AB Q33637263-DD2C5F84-A66A-4347-9B05-B617651A1614 Q33758770-0D47393B-5044-4150-A371-AC2E55750DDB Q33841982-577F3A8F-7F2A-4148-A83C-C8DA0E292116 Q33934146-2437BD38-7D11-4115-8F65-E4146FB189A8 Q34168677-84D20161-4F8F-4FD2-9C9A-1B59DEB8C797 Q34617331-49B9D4AD-93E2-40B0-9EED-4E4D41D3E4C9 Q34653188-3FD203A7-5FAC-426D-A335-08F76705D260 Q35075734-CC502E25-3B86-42E7-A6B2-1D91A2619709 Q35574209-DE615B33-F5C3-4A5A-93E3-5AD8A11114F0 Q35651275-0F186B7B-AF85-4BF4-B442-0C22DF17B6D9 Q35651902-C85A9166-6644-4399-9D05-15F4EE12EDCA Q36105880-242F4A66-F838-490F-B453-BE9D2E12A285 Q36109029-5682DE58-9BDA-465A-BB2B-2A7E77ADF92C Q36129895-11E77F8E-79E1-4156-9644-89E8AF6C96D3 Q36191982-FC7E88A9-CE50-4436-92C9-BFF18F919884 Q36438962-A2C8B00B-19EA-4926-843B-B1366A7B1221 Q37201160-9B9DBD6F-C9D7-4662-962D-1659335A1E1B Q37346447-79917360-086D-49AE-9D43-B98E9FDB3549 Q37422972-023C8896-5ABF-47D8-997D-1E2237B4F896 Q37644025-8216D6EF-4C59-466B-A161-3C1C9C66C5F7 Q37798083-F14D18FB-21D9-4C1C-839C-AAEB831C71AC Q38214775-E72CC1B8-1423-4B77-97A2-8EA595676609 Q38756361-1E940D12-4EDD-4362-BA21-D66A27A26984 Q39798516-3E293ECC-F046-46C3-BBCF-72215418B5FA Q39997493-F921D497-65FD-4E07-8E9B-C458B7F5343C Q40161245-A222887D-BC5C-463C-9AA4-A4B55A0E1D83 Q40529713-527194EE-3B25-4A12-B89B-5DFE9F86446F Q42322516-DC3AB726-F491-439B-8BA3-40570BEACB39 Q42574574-35549F4B-8FD1-49BE-8684-5C8AFD1D64AE Q43918597-61E63B0F-653B-4659-BC0E-CF02AAF2218B Q44940478-65867D16-2019-416F-9707-BBB1E2E57326 Q45090803-FFF3C0C7-EF1E-43DA-A61C-C1AFB98F8616 Q47298251-C34D3E43-DE1E-4A13-A26D-05AC31FE84D2 Q48013238-E229C5EA-C7C7-4404-9881-FD1072F843F4

P2860

Killing cancer cells by targeted drug-carrying phage nanomedicines

http://www.wikidata.org/entity/Q21256651

description

2008 nî lūn-bûn

@nan

2008 թուականին հրատարակուած գիտական յօդուած

@hyw

2008 թվականին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Killing cancer cells by targeted drug-carrying phage nanomedicines

@ast

Killing cancer cells by targeted drug-carrying phage nanomedicines

@en

Killing cancer cells by targeted drug-carrying phage nanomedicines

@en-gb

Killing cancer cells by targeted drug-carrying phage nanomedicines

@nl

type

label

Killing cancer cells by targeted drug-carrying phage nanomedicines

@ast

Killing cancer cells by targeted drug-carrying phage nanomedicines

@en

Killing cancer cells by targeted drug-carrying phage nanomedicines

@en-gb

Killing cancer cells by targeted drug-carrying phage nanomedicines

@nl

prefLabel

Killing cancer cells by targeted drug-carrying phage nanomedicines

@ast

Killing cancer cells by targeted drug-carrying phage nanomedicines

@en

Killing cancer cells by targeted drug-carrying phage nanomedicines

@en-gb

Killing cancer cells by targeted drug-carrying phage nanomedicines

@nl

P1433

Q21256651-44CAE60F-37BE-4464-BFA3-C7F8F43E9F20

P1476

Q21256651-663368D4-E289-40B6-BC15-B39E5977BB84

P2093

Q21256651-B3393F7F-541C-4EF0-8998-539EB163C107

P2860

Q21256651-026848CE-E1C1-4F8A-9C7E-E4C4A36ADE38

Q21256651-046B0863-AFD2-4FB7-AC21-2C30BD474679

Q21256651-04B169FA-1413-4594-90F5-9989809A6402

Q21256651-0581C9A0-508D-4E8A-8E27-150B9EA3799B

Q21256651-05900D11-84D7-44BD-BC69-9F9F63F394AE

Q21256651-0AAB1725-AE6A-4E91-AB3E-61216BFCC2B2

Q21256651-0E871023-CCC0-468E-97B9-8BE1B98C50AA

Q21256651-110B39E5-9124-434A-A5C8-7B11377DC05E

Q21256651-1C6A715B-1E7B-4BE7-8320-02E18789A890

Q21256651-31395E81-A113-4F20-9448-296B1C31B006

P2888

Q21256651-35575376-D204-4E42-9C66-14561473DA73

P304

Q21256651-3B4969E6-9E89-4BF9-B304-FA18A8AA4DAB

P31

Q21256651-CBD8805F-AFB2-4599-ABA7-0BE9191EA5F3

P3181

Q21256651-362F21DD-657C-471B-987D-18329BBA7E7E

P356

Q21256651-3D0148E6-BA5F-45F6-8A8C-4309DC9B8B02

P407

Q21256651-42B6D9B2-8D00-401C-ACB8-97F6D9EB454A

P433

Q21256651-252470A3-AFF5-4570-AA12-7949EB9A633F

P478

Q21256651-0E86F8C5-CDEF-4736-98F5-DA25DF3F6C38

P50

Q21256651-866FCE42-BC81-4927-B794-D6880FEFE45B

Q21256651-DBD54CCE-EFD4-411B-AFF2-3D88160F241E

P577

Q21256651-C3724605-F27B-40EB-ABED-2FDBCBA11D80

P5875

Q21256651-22BDA697-E2A6-49EC-90F5-54B1971B1A18

P6179

Q21256651-3D2C6D1A-0BB1-40A0-8BF2-1005089B4779

P698

Q21256651-E2BFD7BF-C6A9-4641-89B8-D9BBE3585F6C

P932

Q21256651-59BFEDF2-0D07-4FBA-AA72-099051941704

P3181

P356

P1433

BMC Biotechnology

P1476

Killing cancer cells by targeted drug-carrying phage nanomedicines

@en

P2093

Hagit Bar

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting antibacterial agents by using drug-carrying filamentous bacteriophages

Targeted drug-carrying bacteriophages as antibacterial nanomedicines

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

Cancer nanotechnology: opportunities and challenges

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Toward selection of internalizing antibodies from phage libraries.

Targeted gene delivery to mammalian cells by filamentous bacteriophage.

Engineering M13 for phage display.

Internalizing antibodies and targeted cancer therapy: direct selection from phage display libraries.

Selection of tumor-specific internalizing human antibodies from phage libraries.

P2888

P304

37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3962677

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1472-6750-8-37

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5465731

http://www.w3.org/2001/XMLSchema#string

P6179

1007542702

http://www.w3.org/2001/XMLSchema#string

P698

18387177

http://www.w3.org/2001/XMLSchema#string

P932

2323368

http://www.w3.org/2001/XMLSchema#string